ArticleJournal of asthma and allergy2022

Assessment of Symptoms Control, Pulmonary Function and Related Quality of Life in Asthmatic Patients Treated with Extrafine Beclomethasone Dipropionate/Formoterol Fumarate 100/6 μg pMDI: Results of a Multicenter Observational Study in Romania (ALFRESCO Study).

Ruxandra Ulmeanu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.